Pathology Today
Apr. 29, 2015

6 hours of sleep: Is it enough for some patients?
Obtaining sufficient sleep is a crucial component of proper health maintenance. Some authors have gone so far as to recommend that sleep be considered an additional "vital sign" to be assessed at each healthcare provider visit. There are multiple facets to a comprehensive sleep evaluation for an individual patient; however, one of the most important measures is average sleep duration each night. Although all might agree on the importance of total sleep time, it isn't clear what the nightly target should be. In other words, how much sleep is enough for your patient? Before providing an answer to this surprisingly complex question, it's worth taking the time to review the science of health outcomes as they relate to sleep.More

Tumor genomics: Sequence normal tissue, too
MedPage Today
The standard approach of analyzing malignant tumors for unique genetic mutations to target therapy may not be sufficient and may, in fact, lead to inappropriate treatment, researchers said. For accuracy, tumor genomes should also be compared with matched samples of DNA from patient's noncancerous tissue, concluded investigators led by Sian Jones, Ph.D., of Personal Genome Diagnostics, in Baltimore, who reported their findings online in Science Translational Medicine. More

Medical schools reboot for 21st century
Medicine has changed a lot in the past 100 years. But medical training hasn't — until now. Spurred by the need to train a different type of doctor, some top medical schools around the U.S. are tearing up the textbooks and starting from scratch. Most medical schools still operate under a model pioneered in the early 1900s by an educator named Abraham Flexner. The University of Michigan is one of many med schools in the midst of a major overhaul of their curricula. More

Your next prescription could be a genome sequence
At Advances in Genome Biology and Technology, one speaker told attendees that the use of genome sequencing to improve patient care is no longer a far-off goal — it's happening today. While you won't encounter genome sequencing on an average visit to the ER, there are certain clinical areas where this technology has indeed become routine: cancer, pediatric care, the diagnosis and treatment of ultra rare diseases, and a few others. More

As CMS becomes lenient, providers tackle patient engagement
EHR Intelligence
While patient engagement remains a top priority for many medical organizations across the country, the Centers for Medicare & Medicaid Services released a proposed ruling modifying meaningful use requirements and specifically relenting on a major patient engagement objective. Previously, stage 2 meaningful use requirements called for 5 percent of a provider's patient base to access, download and/or transmit their electronic health information, but now this objective has been changed for the years 2015 to 2017 in the proposed ruling. More

FSU, Sarasota Memorial to start residency program
Bradenton Herald
Knowing that most doctors who go to school in Florida don't practice in the state if they do their residencies elsewhere, Florida State University and Sarasota Memorial Hospital have agreed to start an internal medicine residency program in early 2017. The school and hospital signed the deal in March. More

New collaboration brings comprehensive genomic profiling to UC Davis
News Medical
The UC Davis Comprehensive Cancer Center and the Department of Pathology and Laboratory Medicine have entered into a collaboration with Foundation Medicine, a leading molecular information company. The collaboration brings comprehensive genomic profiling into standard of care at UC Davis, allowing physicians to prescribe the most effective, targeted cancer treatments to patients based on the genomic information specific to each individual's cancer. More

New breast cancer gene identified
Medical Xpress
A new breast cancer gene has been identified in a study led by Women's College Hospital (WCH) researcher Dr. Mohammad Akbari, who is also an assistant professor with the Dalla Lana School of Public Health at the University of Toronto. The study, which was published online in Nature Genetics, describes how mutations in a gene called RECQL are strongly linked to the onset of breast cancer in two populations of Polish and French-Canadian women.More